reports
- ABGSC Construct. & Real Estate Research
- Fredrik Stensved
- Markus Henriksson
- Viktor Stenlöf
Foresight Leverages NVIDIA Jetson Orin to Introduce Novel 360-degree 3...
Foresight Leverages NVIDIA Jetson Orin to Introduce Novel 360-degree 3D Perception Solution NVIDIA Jetson AGX Orin system-on-module is used to accelerate autonomous agriculture and heavy machinery projects Ness Ziona, Israel, May 08, 2024 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in automotive vision solutions, has announced a major breakthrough with the development of Dragonfly Vision™, its cutting-edge 360-degrees 3D perception solution, based on the NVIDIA Jetson AGX Orin platform, designed for power-o...
Payment of dividend
Payment of dividend Payment of dividend Regulatory release 8 May 2024, 2 p.m. The Ordinary General Meeting of Kinepolis Group NV has decided today to pay out a dividend of € 0,55 gross per share to the shareholders (€ 0,385 net after deduction of 30% withholding taxes). The dividend will be paid out as from 15 May 2024. The ex coupon date is fixed at 13 May 2024 and the record date at 14 May 2024. KINEPOLIS GROUP NV Public limited company that is making or has made a public appeal to savingsEeuwfeestlaan 20, 1020 BrusselsEnterprise Number VAT BE 0415.928.179 RLP Brussels
USARAD, Nanox’s Teleradiology Subsidiary, Awarded Accreditation from T...
USARAD, Nanox’s Teleradiology Subsidiary, Awarded Accreditation from The Joint Commission Company earns Gold Seal of Approval® for Ambulatory Health Care Accreditation PETACH TIKVA, Israel, May 08, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that its wholly-owned subsidiary, USARAD Holdings, Inc., a leading provider of teleradiology services, has earned The Joint Commission’s Gold Seal of Approval® for Ambulatory Health Care Accreditation for the sixth time by demonstrating continu...
First Merchants Corporation Announces Cash Dividend
First Merchants Corporation Announces Cash Dividend MUNCIE, Ind., May 08, 2024 (GLOBE NEWSWIRE) -- First Merchants Corporation declared a cash dividend on May 7, 2024 of $0.35 per share. The dividend is payable on June 21, 2024, to shareholders of record as of June 7, 2024. For purposes of broker trading, the ex-date of the cash dividend is June 6, 2024. About First Merchants Corporation: First Merchants Corporation is a financial holding company headquartered in Muncie, Indiana. The Corporation has one full-service bank charter, First Merchants Bank. The Bank also operates as First...
LGI Homes Announces its Second Community in the Modesto Market
LGI Homes Announces its Second Community in the Modesto Market RIVERBANK, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) today announced the opening of its second community in the Modesto, California, market, . This incredible community offers a variety of one and two-story homes and is located northeast of Modesto in the friendly town of Riverbank. “We are excited to be a part of the tremendous growth here in Riverbank. Diamond Bar East is so close to everything and offers an easy commute to the Bay Area. However, you don’t need to go anywhere because everything...
Intermex Reports First Quarter Results
Intermex Reports First Quarter Results Company generates strong earnings and margins, continued execution of omnichannel strategy Company to Host Conference Call Today at 9 a.m. ET MIAMI, May 08, 2024 (GLOBE NEWSWIRE) -- International Money Express, Inc. (NASDAQ: IMXI) (“Intermex” or the “Company”), one of the nation’s leading omnichannel money transfer services to Latin America and the Caribbean, today reported strong operating results for the first quarter of 2024. Financial performance highlights for the first quarter of 2024 compared with the same period last year are: Revenues of...
Keros Therapeutics Reports Recent Business Highlights and First Quarte...
Keros Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results LEXINGTON, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta (“TGF-ß”) family of proteins, today provided a business update and reported financial results for the quarter ended March 31, 2024. “Keros remain...
Fulcrum Therapeutics Announces Publication of Results from Phase 2b Cl...
Fulcrum Therapeutics Announces Publication of Results from Phase 2b Clinical Trial of Losmapimod in Facioscapulohumeral muscular dystrophy (ReDUX4) in The Lancet Neurology ― Phase 2b ReDUX4 clinical trial indicates improvements in functional, structural, and patient-reported outcomes; findings informed the design and choice of efficacy endpoints in the ongoing Phase 3 clinical trial― ― Topline data for the Phase 3 REACH clinical trial of losmapimod in FSHD expected during 4Q’24― CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-sta...
Gen Z Consumers Are Using Credit More, and Differently, than Their Mil...
Gen Z Consumers Are Using Credit More, and Differently, than Their Millennial Counterparts at the Beginning of their Credit Journeys New TransUnion study finds Gen Z borrowers lean more heavily on credit cards and auto loans LAS VEGAS, May 08, 2024 (GLOBE NEWSWIRE) -- Gen Z consumers are tapping into credit at higher levels than their Millennial counterparts did in the early stages of adulthood (ages 22-24). TransUnion (NYSE: TRU) released these findings today at the company’s 2024 Financial Services Summit, attended by nearly 300 global financial services executives. The new TransUnio...
IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO
IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO Assumes leadership role as Company anticipates multiple near-term clinical milestones Brings extensive leadership and experience in drug development and business strategy LAWRENCEVILLE, N.J., May 08, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing non-viral DNA-mediated immunotherapy and next-generation vaccines, today announced the appointment of Stacy R. Lindborg, Ph.D. as President and Chief Executive Officer, effective May 13, 2024. Dr. Lindbo...
Standard Lithium and Equinor Form Partnership to Develop South West Ar...
Standard Lithium and Equinor Form Partnership to Develop South West Arkansas and East Texas Lithium Projects Equinor Commits to Contribute up to a US$160 million Gross Investment for a 45% interest in two special purpose entities with SLI to develop a sustainable lithium business in the United States VANCOUVER, British Columbia, May 08, 2024 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV:SLI) (NYSE American:SLI) (FRA:S5L), a leading near-commercial lithium development company, today announced the closing of a landmark strategic partnership (the “Tr...
Puma Launches 2024 Exploration Program at Jonpol Gold
Puma Launches 2024 Exploration Program at Jonpol Gold RIMOUSKI, Quebec, May 08, 2024 (GLOBE NEWSWIRE) -- Puma Exploration Inc. (TSXV: PUMA, OTCQB: PUMXF) (the "Company" or "Puma") is pleased to launch its 2024 exploration program at its 100%-owned Jonpol Gold property located 8 km east of its Williams Brook property in Northern New Brunswick. As outlined in its News Release of January 17, 2024, Puma is expanding its regional exploration fieldwork to prospective areas of the Williams Brook Project to identify additional priority targets and add to the Williams Brook gold inventory. ...
Monster Beverage Corporation Commences Modified Dutch Auction Tender O...
Monster Beverage Corporation Commences Modified Dutch Auction Tender Offer to Purchase Up to $3.0 Billion of Its Outstanding Common Stock CORONA, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Monster Beverage Corporation (NASDAQ: MNST) today announced that it has commenced a modified “Dutch auction” tender offer to purchase shares of its common stock for cash at a price per share of not less than $53.00 and not greater than $60.00, for a maximum aggregate purchase price of up to $3.0 billion. The tender offer begins today, May 8, 2024, and will expire at 11:59 p.m., New York City time, on June...
Lion One Drills 4.8 m of 30.48 g/t Gold in Near-Mine Expansion at Tuva...
North Vancouver, British Columbia--(Newsfile Corp. - May 8, 2024) - Lion One Metals Limited (TSXV: LIO) (OTCQX: LOMLF) (ASX: LLO) ("Lion One" or the "Company") is pleased to report significant new high-grade gold results from near-mine expansion drilling at its 100% owned Tuvatu Alkaline Gold Project in Fiji.Assay results are presented here for near-mine expansion drilling in the Murau down-dip extension and SKL areas of Tuvatu. Both areas are outside the current mine plan yet are close to current underground workings and are being brought into the mine plan for late 2024 and 2025. The Murau d...
Intra-Cellular Therapies to Participate in Two Upcoming Investor Confe...
Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will participate in two upcoming investor conferences: 2024 RBC Capital Markets Global Healthcare ConferenceTuesday, May 14, 2024 at 10:00 a.m. ET in New York, NY Bank of America Healthcare Conference 2024Thursday, May 16, 2024 at 9:20 a.m. PT (12:20 p.m. ET) in La...
Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2...
Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- , Inc (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it will host a webcast on Tuesday, May 14, 2024, at 4:30 p.m. Eastern Time to discuss the Company’s financial results and provide a business update for the first quarter ended March 31, 2024. Webcast InformationDate: Tuesday, May 14...
Aspira Women’s Health to Announce First Quarter Earnings Results and H...
Aspira Women’s Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15 AUSTIN, Texas, May 08, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced that the Company will report its financial results for the three months ended March 31, 2024, on Wednesday, May 15, 2024. Management will also host a conference call at 8:30 a.m. Eastern Time to discuss financial results and provide a...
Spero Therapeutics to Report First Quarter 2024 Financial Results and ...
Spero Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on Wednesday, May 15, 2024 CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections, today announced that it will report its first quarter 2024 financial results and provide an update on its business and pipeline on Wednesday, May 15, after the market close. The Company does not inten...
Core Molding Technologies to Participate in the EF Hutton Annual Globa...
Core Molding Technologies to Participate in the EF Hutton Annual Global Conference in NYC COLUMBUS, Ohio, May 08, 2024 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in building products, industrial and utilities, medium and heavy-duty truck and powersports industries across the United States, Canada and Mexico today announced that David Duvall, President and CEO, and John Zimmer, EVP and CFO, will participate in the EF Hutton ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.